Accelerating Drug Candidate Generation with A-Booster

We’re excited to introduce our new integrated drug discovery service, …

Junko Yokoi2026-08-20T01:19:56+00:0012.22.2025|

Biotech Showcase 2026

San Francisco, CA

Junko Yokoi2026-01-20T03:29:02+00:0012.22.2025|

Research article on advanced mass spectrometry analysis of disease-associated Asn-linked glycoconjugates in NGLY1 deficiency has been published

Structural characterization and insights into the formation of …

Junko Yokoi2025-12-17T02:18:45+00:0012.17.2025|

Evaluation of γH2AX Assay for Screening Chromosomal Aberrations

The 54th Annual Meeting of JapaneseEnvironmental Mutagen and Genome Society (JEMS)

Download

Junko Yokoi2025-12-12T02:57:31+00:0012.11.2025|

Axcelead DDP Signs an Agreement with Astellas for HT-ADMET Studies

Fujisawa, Japan, December 11, 2025 – Axcelead Drug …

Junko Yokoi2025-12-10T23:22:31+00:0012.11.2025|

Research Article on Exon Skipping in Alport Syndrome Mouse Model Published in Scientific Reports

Podocyte specific exon skipping after disease onset improves …

Junko Yokoi2025-12-04T23:42:52+00:0012.05.2025|

Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome

Scientific Reports

Junko Yokoi2025-12-05T03:56:11+00:0011.25.2025|

Research article on pharmacological evaluation using a MASH mouse model has been published in Scientific Reports

Differences between Therapeutic Mechanisms of Resmetirom and Semaglutide …

Junko Yokoi2025-12-01T04:19:27+00:0011.21.2025|

DMPK Services

Download

Junko Yokoi2025-11-20T02:19:44+00:0011.20.2025|

Differences between Therapeutic Mechanisms of Resmetirom and Semaglutide against MASH in Western Diet-Fed MC4R-Knockout Mice

Scientific Reports

Junko Yokoi2025-11-21T00:07:06+00:0011.20.2025|